Abstract:Colorectal cancer, encompassing colon and rectal cancer, arises from the epithelial lining of the large bowel. It is most prevalent in Westernised societies and is increasing in frequency as the world becomes more industrialised. Unfortunately, metastatic colorectal cancer is not cured by chemotherapy and the annual number of deaths caused by colorectal cancer, currently 700,000, is expected to rise. Our understanding of the contribution that genetic mutations make to colorectal cancer, although incomplete, is reasonably well advanced. However, it has only recently become widely appreciated that in addition to the ongoing accumulation of genetic mutations, chronic inflammation also plays a critical role in the initiation and progression of this disease. While a robust and tractable genetic model of colorectal cancer in zebrafish, suitable for pre-clinical studies, is not yet available, the identification of genes required for the rapid proliferation of zebrafish intestinal epithelial cells during development has highlighted a number of essential genes that could be targeted to disable colorectal cancer cells. Moreover, appreciation of the utility of zebrafish to study intestinal inflammation is on the rise. In particular, zebrafish provide unique opportunities to investigate the impact of genetic and environmental factors on the integrity of intestinal epithelial barrier function. With currently available tools, the interplay between epigenetic regulators, intestinal injury, microbiota composition and innate immune cell mobilisation can be analysed in exquisite detail. This provides excellent opportunities to define critical events that could potentially be targeted therapeutically. Further into the future, the use of zebrafish larvae as hosts for xenografts of human colorectal cancer tissue, while still in its infancy, holds great promise that zebrafish could one day provide a practical, preclinical personalized medicine platform for the rapid assessment of the metastatic potential and drug-sensitivity of patient-derived cancers.

The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer

Advantages of the zebrafish tumor xenograft model: the evaluation of efficacy in cancer therapy and the application to the study of lncRNAs

Zebrafish xenograft as a tool for the study of colorectal cancer: a review

Zebrafish Xenographs in Oncology and Personalized Medicine

A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish.

Benefits of Zebrafish Xenograft Models in Cancer Research

Zebrafish in Lung Cancer Research.

LncRNA HOXD-AS1 functions as a ceRNA to promote hepatocellular carcinoma metastasis in zebrafish xenograft models

Zebrafish patient avatars in cancer biology and precision cancer therapy

Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy

Quo natas, Danio?—Recent Progress in Modeling Cancer in Zebrafish

Fish Tales: the Use of Zebrafish Xenograft Human Cancer Cell Models.

Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts

Model establishment of xenotransplantation of human breast cancer in zebrafish embryos

Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model

Zebrafish live imaging: a strong weapon in anticancer drug discovery and development

Zebrafish: Speeding Up the Cancer Drug Discovery Process.

A fresh look at zebrafish from the perspective of cancer research

The Study of Glioma by Xenotransplantation in Zebrafish Early Life Stages

Focusing the Spotlight on the Zebrafish Intestine to Illuminate Mechanisms of Colorectal Cancer